Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Itzhak Marcovitch"'
Autor:
Orit Redy Keisar, Victoria Nahum, Lea Yehezkel, Itzhak Marcovitch, Ishay Columbus, Gil Fridkin, Ravit Chen
Publikováno v:
ACS Omega, Vol 6, Iss 8, Pp 5359-5367 (2021)
Externí odkaz:
https://doaj.org/article/3d5d41d5967b4f8b85e218b917c632f9
Publikováno v:
International Journal of Environmental Analytical Chemistry. :1-15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501be484b9328519d661441fc208479a
https://doi.org/10.1080/03067319.2023.2196720
https://doi.org/10.1080/03067319.2023.2196720
Publikováno v:
CLEAN - Soil, Air, Water. 46:1700142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c96fcba8083de69a8950921b8702eb2e
https://doi.org/10.1002/clen.201700142
https://doi.org/10.1002/clen.201700142
Autor:
Niva Natan, Nira Bar-Ner, Itzhak Marcovitch, Hagar Sonego, Rachel Brandeis, Abraham Fisher, Zipora Pittel, Rachel Haring, Inbal Egozi, Michal Kliger-Spatz
Publikováno v:
Journal of Molecular Neuroscience. 20:349-356
M1 muscarinic receptors (M1 mAChRs) play a role in an apparent linkage of three major hallmarks of Alzheimer's disease (AD): beta-amyloid (Abeta) peptide; tau hyperphosphorylation and paired helical filaments (PHFs); and loss of cholinergic function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e248057e74a82b0a89fd32b3494b06f1
https://doi.org/10.1385/jmn:20:3:349
https://doi.org/10.1385/jmn:20:3:349
Autor:
Niva Natan, Itzhak Marcovitch, Rachel Haring Nira Bar-Ner, Hagar Sonego, Michal Kliger-Spatz, Abraham Fisher, Rachel Brandeis, Zipora Pittel
Publikováno v:
Journal of Molecular Neuroscience. 19:145-153
The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren's Syndrome), AF150(S) and AF267B--1) are neurotrophic and synergistic with neurotrophins such as nerve growth factor and epidermal growth factor; 2) elev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c7c29934d68f9757c6099a183d5139
https://doi.org/10.1007/s12031-002-0025-3
https://doi.org/10.1007/s12031-002-0025-3
Publikováno v:
Environmental sciencetechnology. 46(7)
A study of the volatilization rate of the nerve agent VX (O-ethyl S-2-(N,N-diisopropylamino)ethyl methylphosphonothiolate) from various urban matrices in a specially designed climatic chamber (model system) is described. The performance of the model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56c58b894c4d68784798cec6759e062
https://pubmed.ncbi.nlm.nih.gov/22413893
https://pubmed.ncbi.nlm.nih.gov/22413893
Autor:
Noëlle Bons, Niva Natan, Nira Bar-Ner, Itzhak Marcovitch, Hagar Sonego, Zipora Pittel, Rachel Brandeis, Rachel Haring
Publikováno v:
Cholinergic Mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72bef2cd0403c30ea60d21bbcef90289
https://doi.org/10.3109/9780203493878-50
https://doi.org/10.3109/9780203493878-50
Autor:
Abraham, Fisher, Zipora, Pittel, Rachel, Haring, Nira, Bar-Ner, Michal, Kliger-Spatz, Niva, Natan, Inbal, Egozi, Hagar, Sonego, Itzhak, Marcovitch, Rachel, Brandeis
Publikováno v:
Journal of molecular neuroscience : MN. 20(3)
M1 muscarinic receptors (M1 mAChRs) play a role in an apparent linkage of three major hallmarks of Alzheimer's disease (AD): beta-amyloid (Abeta) peptide; tau hyperphosphorylation and paired helical filaments (PHFs); and loss of cholinergic function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::debaa083b879ffce61b63e58aa4c0964
https://pubmed.ncbi.nlm.nih.gov/14501019
https://pubmed.ncbi.nlm.nih.gov/14501019
Autor:
Nira Bar-Ner, Rachel Brandeis, Abraham Fisher, Niva Natan, Zipora Pittel, Rachel Haring, Nadine Mestre-Francés, Itzhak Marcovitch, Hagar Sonego, Noëlle Bons
Publikováno v:
Mapping the Progress of Alzheimer’s and Parkinson’s Disease ISBN: 9781475709735
M1 muscarinic receptors (M 1 mAChR) have an important role in cognitive processing relevant to Alzheimer’s disease brains (AD)1–5. M1 mAChR are relatively unchanged in AD1–5 and therefore may serve as a target for an anti-dementia drug treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69edea398f3b792def2ddf79169308a7
https://doi.org/10.1007/978-0-306-47593-1_34
https://doi.org/10.1007/978-0-306-47593-1_34
Autor:
Abraham Fisher, Z. Pittel, Michal Kliger-Spatz, Itzhak Marcovitch, Hagar Sonego, Rachel Brandeis, Rachel Haring, Nira Bar-Ner, Niva Natan
Publikováno v:
Ageing and Dementia Current and Future Concepts ISBN: 9783211837962
The Ml muscarinic agonists AF102B, AF150(S) & AF267B — i) restored cognitive impairments in several animal models for AD with an excellent safety margin; ii) elevated α-APPs levels; iii) attenuated vicious cycles induced by Aβ, and inhibited Aβ-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::844c1156e3e9f46a5da7b41acc28e670
https://doi.org/10.1007/978-3-7091-6139-5_18
https://doi.org/10.1007/978-3-7091-6139-5_18